Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers

Phase 1

Waitlist Available

Led By Arunima Sarkar, MD

Research Sponsored by Hackensack Meridian Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months recruitment efforts (starting on actual study start date)

Summary

This trial is testing if omega-3 supplements can help adults who have ongoing symptoms after recovering from COVID-19. Omega-3s, found in fish oil, might reduce inflammation and improve their condition.

Eligible Conditions

Coronavirus

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months recruitment efforts (starting on actual study start date)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months recruitment efforts (starting on actual study start date)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months recruitment efforts (starting on actual study start date) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Feasibility Study for Omega-3 Fatty Acid Supplementation v. Placebo in Adult Patients to Limit Long Covid Syndrome - Compliance as Captured by the Number of Participants Who Remain Compliant for the Whole Duration of the Study by Taking All Pills Daily

Feasibility Study for Omega-3 Fatty Acid Supplementation v. Placebo in Adult Patients to Limit Long Covid Syndrome - Recruitment as Illustrated by the Number of Screen Failures (Potential Participants Approached But Not Interested in Participating).

Feasibility Study for Omega-3 Fatty Acid Supplementation v. Placebo in Adult Patients to Limit Long Covid Syndrome - Retention as Illustrated by the Number of Participants That Initiate But do Not Complete the Study.

Secondary study objectives

Impact of Omega-3 Supplement on Post-covid Symptoms - Cough

Impact of Omega-3 Supplement on Post-covid Symptoms - Fatigue

Impact of Omega-3 Supplement on Post-covid Symptoms - Loss of Smell

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Study arm - Omega 3 supplementExperimental Treatment1 Intervention

Omega-3 (EPA+DHA) - Dose is 2,100mg per day via 3 mini-capsules, 2x/day (a total of 6 mini-capsules per day). Each capsule has 252mg of EPA and 102mg of DHA.

Group II: Control arm - placeboPlacebo Group1 Intervention

3 Soybean Oil Placebo capsules 2x/day (a total of 6 mini-capsules per day).

Do I qualify?Apply below to find out